Valuation Black Diamond Therapeutics, Inc.
Stocks
BDTX
US09203E1055
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.690 USD | -1.46% |
|
-3.98% | -30.45% |
| 06-29 | Black Diamond Therapeutics, Inc.(NasdaqGS:BDTX) added to Russell 2000 Index | CI |
| 06-29 | Black Diamond Therapeutics, Inc.(NasdaqGS:BDTX) added to Russell 2000 Value Benchmark | CI |
Company Valuation: Black Diamond Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 193.1 | 65.46 | 145.1 | 121.1 | 138.4 | 96.84 | - | - |
| Change | - | -66.1% | 121.66% | -16.54% | 14.33% | -30.05% | - | - |
| Enterprise Value (EV) | -16.69 | -57.35 | 145.1 | 121.1 | 138.4 | 96.84 | 96.84 | 96.84 |
| Change | - | -243.68% | 353.01% | -16.54% | 14.33% | -30.05% | 0% | 0% |
| P/E | -1.54x | -0.71x | -1.49x | -1.69x | 6.23x | -2.61x | -1.68x | -1.61x |
| PBR | 0.98x | - | - | - | - | - | - | - |
| PEG | - | 0x | 0.1x | 0.1x | -0x | 0x | -0x | -0.38x |
| Capitalization / Revenue | - | - | - | - | 1.98x | 17.4x | - | - |
| EV / Revenue | - | - | - | - | 0x | 17.4x | - | - |
| EV / EBITDA | 0x | 0x | - | -0x | 0x | -2.09x | -1.89x | -1.52x |
| EV / EBIT | 0x | 0x | -0x | -0x | 0x | -2.17x | -1.31x | -0.99x |
| EV / FCF | 0x | 0x | -0x | -0x | 0x | -2.31x | -2.2x | 6.05x |
| FCF Yield | -53.3% | -130% | -46% | -51.5% | 21.4% | -43.4% | -45.4% | 16.5% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -3.47 | -2.52 | -1.88 | -1.27 | 0.39 | -0.6478 | -1.005 | -1.047 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | 70 | 5.556 | - | - |
| EBITDA 1 | -126.7 | -92.32 | - | -78.44 | 20.2 | -46.4 | -51.15 | -63.9 |
| EBIT 1 | -126.9 | -92.83 | -86.46 | -78.78 | 19.87 | -44.69 | -74.05 | -97.58 |
| Net income 1 | -125.6 | -91.17 | -82.44 | -69.68 | 22.37 | -40.47 | -70.04 | -94.17 |
| Net Debt | -209.8 | -122.8 | - | - | - | - | - | - |
| Reference price 2 | 5.330 | 1.800 | 2.810 | 2.140 | 2.430 | 1.690 | 1.690 | 1.690 |
| Nbr of stocks (in thousands) | 36,229 | 36,366 | 51,635 | 56,585 | 56,975 | 57,302 | - | - |
| Announcement Date | 17/03/22 | 09/03/23 | 12/03/24 | 06/03/25 | 16/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.61x | - | - | - | 96.84M | |
| 21.25x | 6.51x | 14.24x | 1.5% | 56.54B | |
| 31.6x | 7.8x | 24.02x | 0.05% | 53.6B | |
| -17.91x | 4.18x | -7.32x | -.--% | 22.91B | |
| -38.06x | 12.21x | -36.05x | -.--% | 21.37B | |
| 25.45x | 4.98x | 13.18x | -.--% | 20.27B | |
| 24.28x | 4.73x | 15.36x | -.--% | 17.56B | |
| -737.38x | 35.03x | -3943.97x | -.--% | 14.75B | |
| 40.7x | 16.37x | 42.16x | 0.09% | 13.53B | |
| 16.73x | 4.82x | 11.24x | -.--% | 13.33B | |
| Average | -63.60x | 10.74x | -429.68x | 0.18% | 23.4B | |
| Weighted average by Cap. | -32.00x | 9.11x | -238.39x | 0.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BDTX Stock
- Valuation Black Diamond Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
